Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer

ABSTRACT: Phase I Study of biweekly combination therapy with S-1, Irinotecan, and Bevacizumab as 1-line Chemotherapy in Patients With Advanced Colorectal Cancer.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2261846 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR